Chicago, IL, November 3, 2022 (PRNewswire) -- Emalex Biosciences announced the closing of an upsized and oversubscribed $250 million Series D funding round that will fund a Phase 3 clinical trial and potential commercialization of a new class of drug for patients with Tourette Syndrome.
Read full article here.
Wilmington, DE, September 25, 2023 (Reuters) -- Enovis Corp (ENOV.N), a leader in orthopedic bracing, surgical implants, and footcare solutions, announced on Monday its strategic acquisition of Lima
Baltimore, MD, September 12, 2023 (Business Wire) -- Protaryx Medical, announces, David Mester, MBA, as its newly appointed Chief Executive Officer (CEO). With a remarkable career spanning more tha
Monrovia, CA, September 25, 2023 (PRNewswire) -- AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that it has
